Cargando…
Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial
BACKGROUND: To evaluate the efficacy of 1% and 2% rebamipide clear solution in the treatment of dry eye disease (DED). METHODS: Two hundred twenty patients with DED were randomly assigned to one of three groups: the 1% rebamipide, 2% rebamipide, or placebo (eye drops containing the same ingredients,...
Autores principales: | Eom, Youngsub, Chung, So Hyang, Chung, Tae-Young, Kim, Jae Yong, Choi, Chul Young, Yoon, Kyung Chul, Ko, Byung Yi, Kim, Hong Kyun, Kim, Mee Kum, Lee, Hyung Keun, Song, Jong Suk, Hyon, Joon Young, Seo, Kyoung Yul, Lee, Jong Soo, Kim, Hyo Myung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398964/ https://www.ncbi.nlm.nih.gov/pubmed/37537533 http://dx.doi.org/10.1186/s12886-023-03004-1 |
Ejemplares similares
-
Korean Guidelines for the Diagnosis and Management of Dry Eye: Development and Validation of Clinical Efficacy
por: Hyon, Joon Young, et al.
Publicado: (2014) -
Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2019) -
Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019) -
Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2020) -
Comparison of Anterior, Posterior, and Total Corneal Astigmatism Measured Using a Single Scheimpflug Camera in Healthy and Keratoconus Eyes
por: Choi, Young, et al.
Publicado: (2018)